Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by redrillon Jul 13, 2010 2:05pm
441 Views
Post# 17265864

RE: RE: 0.30

RE: RE: 0.30"for sure we're not going to see approval"

Many will disagree with that statement................Could the outstanding issues possibly be 1)pricing for multiple applications if other than Lux is marketing this drug?  2)  control of off label usage as this drug definitely seems to have several viable uses other than opthamalogy. 3) data submitted from both transplant and psoarasis trials, issue as to when application for the use in these areas is to be submitted.......The speculation is quite entertaining on this board!!!!!
<< Previous
Bullboard Posts
Next >>